Abnormal Liver Function Test in Patients Infected with Coronavirus (SARS-CoV-2): A Retrospective Single-Center Study from Spain
dc.contributor.author | Flores Perojo, Vicente | |
dc.contributor.author | Macías Rodríguez, Ricardo U. | |
dc.contributor.author | Ruiz Margáin, Astrid | |
dc.contributor.author | Regueiro González-Barros, José Ramón | |
dc.contributor.author | Ávila, Matias A | |
dc.contributor.author | Trautwein, Christian | |
dc.contributor.author | Bañares Cañizares, Rafael | |
dc.contributor.author | Bosch, Jaume | |
dc.contributor.author | Estévez Vázquez, Olga | |
dc.contributor.author | Martínez Naves, Eduardo | |
dc.contributor.author | Cubero Palero, Francisco Javier | |
dc.contributor.author | Nevzorova, Yulia | |
dc.contributor.author | Benede Ubieto, Raquel | |
dc.date.accessioned | 2024-02-01T15:49:25Z | |
dc.date.available | 2024-02-01T15:49:25Z | |
dc.date.issued | 2021-03-03 | |
dc.description.abstract | Abstract: The outbreak of the novel coronavirus SARS-CoV-2 epidemic has rapidly spread and still poses a serious threat to healthcare systems worldwide. In the present study, electronic medical records containing clinical indicators related to liver injury in 799 COVID-19-confirmed patients admitted to a hospital in Madrid (Spain) were extracted and analyzed. Correlation between liver injury and disease outcome was also evaluated. Serum levels of Alanine aminotransferase (ALT), Aspartate aminotransferase (AST), Gamma-glutamyltransferase (GGT), Alkaline phosphatase (ALP), Lactate dehydrogenase (LDH) and AST/ALT ratio were elevated above the Upper Limit of Normal (ULN) in 25.73%, 49.17%, 34.62%, 24.21%, 55.84% and 75% of patients, respectively. Interestingly, significant positive correlation between LDH levels and the AST/ALT ratio with disease outcome was found. Our data showed that SARS-CoV-2 virus infection leads to mild, but significant changes in serum markers of liver injury. The upregulated LDH levels as well as AST/ALT ratios upon admission may be used as additional diagnostic characteristic for COVID-19 patients. | en |
dc.description.department | Depto. de Inmunología, Oftalmología y ORL | |
dc.description.faculty | Fac. de Medicina | |
dc.description.refereed | TRUE | |
dc.description.sponsorship | Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas | |
dc.description.sponsorship | Instituto de Salud Carlos III | |
dc.description.sponsorship | Fondo Europeo de Desarrollo Regional | |
dc.description.sponsorship | Gobierno de Navarra | |
dc.description.sponsorship | Ministerio de Economía, Comercio y Empresa (España) | |
dc.description.sponsorship | German Research Foundation | |
dc.description.sponsorship | Ramón y Cajal | |
dc.description.sponsorship | Universidad Complutense de Madrid | |
dc.description.sponsorship | Santander Universidades | |
dc.description.status | pub | |
dc.identifier.citation | Benedé-Ubieto R, Estévez-Vázquez O, Flores-Perojo V, Macías-Rodríguez RU, Ruiz-Margáin A, Martínez-Naves E, Regueiro JR, Ávila MA, Trautwein C, Bañares R, Bosch J, Cubero FJ, Nevzorova YA. Abnormal Liver Function Test in Patients Infected with Coronavirus (SARS-CoV-2): A Retrospective Single-Center Study from Spain. J Clin Med. 2021 Mar 3;10(5):1039. doi: 10.3390/jcm10051039. PMID: 33802486; PMCID: PMC7959465. | |
dc.identifier.doi | 10.3390/ jcm10051039 | |
dc.identifier.essn | 2077-0383 | |
dc.identifier.officialurl | https//doi.org/10.3390/ jcm10051039 | |
dc.identifier.relatedurl | https://www.mdpi.com/2077-0383/10/5/1039 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14352/97878 | |
dc.issue.number | 5 | |
dc.journal.title | Journal of Clinical Medicine | |
dc.language.iso | eng | |
dc.page.initial | 1039 | |
dc.publisher | MPDI | |
dc.relation.projectID | info:eu-repo/grantAgreement/MINECO//PI16%2F01126/ES/Nuevas aproximaciones experimentales al diagnóstico y tratamiento del colangiocarcinoma/ | |
dc.relation.projectID | 58/17 | |
dc.relation.projectID | SAF2014-54708-R | |
dc.relation.projectID | SAF2016- 78711 | |
dc.relation.projectID | SAF2017-87919-R | |
dc.relation.projectID | EXOHEP-CM S2017/BMD-3727 | |
dc.relation.projectID | NanoLiver-CM Y2018/NMT-4949 | |
dc.relation.projectID | ERAB Ref. EA 18/14 | |
dc.relation.projectID | AMMF 2018/117 | |
dc.relation.projectID | UCM 25/2019 | |
dc.relation.projectID | COST Action CA17112 | |
dc.relation.projectID | SFB/TRR57/P04 | |
dc.relation.projectID | SFB 1382-403224013/A02 | |
dc.relation.projectID | DFG NE 2128/2-1 | |
dc.relation.projectID | RYC-2014-15242 | |
dc.relation.projectID | info:eu-repo/grantAgreement/MINECO//RYC-2015-17438/ES/RYC-2015-17438/ | |
dc.relation.projectID | CT82/20-CT83/20 | |
dc.relation.projectID | info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016/SAF2017-87919-R/ES/INTERDEPENDENCIA DEL ESTRES OXIDATIVO Y LA INFLAMACION DURANTE LA ENFERMEDAD HEPATICA CRONICA: UNA NUEVA HERRAMIENTA TERANOSTICA/ | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | en |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject.cdu | 578 | |
dc.subject.cdu | 61 | |
dc.subject.keyword | SARS-CoV-2 | |
dc.subject.keyword | Liver injury | |
dc.subject.keyword | Pandemic | |
dc.subject.keyword | AST/ALT ratio | |
dc.subject.keyword | Ferritin | |
dc.subject.ucm | Ciencias Biomédicas | |
dc.subject.ucm | Biología | |
dc.subject.ucm | Biología molecular (Biología) | |
dc.subject.ucm | Gastroenterología y hepatología | |
dc.subject.unesco | 2420 Virología | |
dc.subject.unesco | 24 Ciencias de la Vida | |
dc.subject.unesco | 2410 Biología Humana | |
dc.title | Abnormal Liver Function Test in Patients Infected with Coronavirus (SARS-CoV-2): A Retrospective Single-Center Study from Spain | en |
dc.type | journal article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 10 | |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | f497ca90-fd08-440c-a7a2-abaa7dee0039 | |
relation.isAuthorOfPublication | 6bae749f-43e7-481d-9c17-3754318969db | |
relation.isAuthorOfPublication | fa6eef80-d726-48f3-afbf-85cdfa2036aa | |
relation.isAuthorOfPublication | 520f2d09-78ca-4d34-b7bc-eb333044ae32 | |
relation.isAuthorOfPublication | b3877679-0fbd-42e6-8541-1efeb2df768a | |
relation.isAuthorOfPublication | 5f15ba54-984a-437d-899a-14563423e77e | |
relation.isAuthorOfPublication | 6c3ad8fb-78ef-49b7-aad4-020d1050e8f4 | |
relation.isAuthorOfPublication | 6c3ad8fb-78ef-49b7-aad4-020d1050e8f4 | |
relation.isAuthorOfPublication.latestForDiscovery | fa6eef80-d726-48f3-afbf-85cdfa2036aa |
Download
Original bundle
1 - 1 of 1
Loading...
- Name:
- abnormal liver functions covid.pdf
- Size:
- 610.52 KB
- Format:
- Adobe Portable Document Format